GoodRx Holdings (GDRX) EBT (2019 - 2026)

GoodRx Holdings' EBT history runs 8 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• In Q1 2026, EBT fell 66.17% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $45.5 million (down 4.86% YoY), while the FY2025 annual figure was $56.5 million, up 79.71% from the prior year.
• EBT came in at $5.6 million for Q1 2026 at GoodRx Holdings, down from $14.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $19.6 million in Q2 2025 to a low of -$46.6 million in Q3 2023.
• A 5-year average of $872588.2 and a median of $6.1 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT slumped 2154.52% in 2022 and jumped 5588.74% in 2025, its largest moves.
• GoodRx Holdings' EBT stood at -$4.7 million in 2022, then slumped by 419.18% to -$24.6 million in 2023, then surged by 146.31% to $11.4 million in 2024, then gained by 24.4% to $14.2 million in 2025, then slumped by 60.27% to $5.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $5.6 million, $14.2 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison